dasatinib "pharmascience" 80 mg filmovertrukne tabletter
pharmascience international ltd - dasatinib - filmovertrukne tabletter - 80 mg
duloxetine "medical valley" 30 mg enterokapsler, hårde
medical valley invest ab - duloxetinhydrochlorid - enterokapsler, hårde - 30 mg
duloxetine "medical valley" 60 mg enterokapsler, hårde
medical valley invest ab - duloxetinhydrochlorid - enterokapsler, hårde - 60 mg
seretide 50+250 mikrog./dosis inhalationspulver, afdelt
glaxosmithkline pharma a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+250 mikrog./dosis
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
dasatinib "pharmascience" 50 mg filmovertrukne tabletter
pharmascience international ltd - dasatinib - filmovertrukne tabletter - 50 mg
dasatinib "pharmascience" 70 mg filmovertrukne tabletter
pharmascience international ltd - dasatinib - filmovertrukne tabletter - 70 mg
budesonid "pharmachemie" 400 mikrogram inhalationspulver, hård kapsel
teva b.v. - budesonid - inhalationspulver, hård kapsel - 400 mikrogram
dexanova 1 mg/ml øjendråber, opløsning
pharmaselect international beteiligungs gmbh - dexamethasonnatriumphosphat - øjendråber, opløsning - 1 mg/ml